middle.news
Orthocell Breaks Records and Launches Remplir™ in US Nerve Repair Market
9:08am on Wednesday 9th of July, 2025 AEST
•
Healthcare
Read Story
Orthocell Breaks Records and Launches Remplir™ in US Nerve Repair Market
9:08am on Wednesday 9th of July, 2025 AEST
Key Points
Record FY2025 revenue of A$9.19 million, up 35.8% year-on-year
First US commercial use of Remplir™ after FDA 510(k) clearance in April 2025
Established US distributor network across 25 states with 14 specialist partners
Regulatory approvals secured in Hong Kong, Thailand, Canada, and Brazil
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE